Print Page      Close Window     

Investor Relations

Corporate Profile
Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrated medical technology company focused on developing and commercializing novel technologies for weight loss. Obalon has launched the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit www.obalon.com.
IR Kit
Obalon Presentation
Second Quarter 2017 Press Release
Second Quarter 2017 10Q
2016 10K
424B Filing

Stock Quote
OBLN (Common Stock) $8.56  - 0.28 (3.17%)
ExchangeNASDAQ
Volume37,937
Today's Open$8.78
Previous Close$8.84
Data as of 08/21/17 4:00 p.m. ET    Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.


Stock Chart
Stock chart for: OBLN.O.  Currently trading at $8.56 with a 52 week high of $15.88 and a 52 week low of $7.98.

Upcoming Events
There are currently no events scheduled.